{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Boards of Directors", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Appointments and Executive Changes", "name": "subject", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/10/business/valeant-pharmaceuticals-adds-board-members.html", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "firstname": "Katie", "role": "reported", "organization": "", "rank": 1}], "original": "By KATIE THOMAS"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "legacy": {"wide": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/10/business/10valeant-web1/10valeant-web1-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/10/business/10valeant-web1/10valeant-web1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "434", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "pub_date": "2016-03-10T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant Takes Step to Soothe Investors", "main": "Valeant Pharmaceuticals Adds Board Members"}, "print_page": "2", "snippet": "Valeant said it had named three new directors to its board, including an executive from a major shareholder, Pershing Square Capital Management.", "_id": "56e0328d38f0d836dc036bd2", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals, which is under scrutiny for its drug-pricing practices, says it is adding three new members to its board, including one from shareholder Pershing Square Capital Management; stock rises."}